Latest News

Cognizant CEO honored for helping redefine enterprise AI transformation through workforce reinvention and next-generation operating models TEANECK, N.J., Aug. 27, 2026 /PRNewswire/ -- Cognizant (Nasda

Kansas City Fed President Jeffrey Schmid said Thursday that inflation has been "stubborn" and "sticky" though he did not commit to supporting an interest rate hike. However, he said he doesn't see the

Hagens Berman Urges Investors with Significant Losses to Contact the Firm KEY DATES AND FIGURES Class Period: Dec. 10, 2025 - May 27, 2026 Lead Plaintiff Deadline: Sept. 4, 2026 Case Page: www.hbsslaw

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman, a national law firm noted for its preeminent work in securities class action litigation, notifies investors in HDFC Bank

San Francisco, California--(Newsfile Corp. - August 27, 2026) - National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Followin

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has be

Strattec Security Corporation faces significant macro headwinds from persistent high oil prices and a weakening auto industry outlook. Auto industry forecasts are deteriorating, and management's cost-

This article was written by Doug Nathman, with research by his team at Trefis.

I'm reiterating Siemens Energy AG is reiterated as a Strong Buy with a new $220 price target after robust Q3 2026 results. SMEGF's backlog surged to €162 billion, quarterly revenue rose 19% y/y, and g

Accelleron Industries AG (ACLLY) Q2 2026 Earnings Call Transcript

Zymeworks Inc. is transitioning from a development-stage biotech to a royalty-driven, revenue-generating platform following zanidatamab's FDA approval. Zanidatamab's first-line HER2+ gastroesophageal

Okta remains a Buy, supported by steady revenue growth, expanding enterprise accounts, and improving margins. OKTA's FY27 guidance targets 10-11% revenue growth, 26% non-GAAP operating margin, and 28-

VanEck Morningstar Wide Moat ETF delivered strong recent outperformance, gaining 10.23% versus peers since my last review, driven by deeply discounted valuations and overweighted software stocks. MOAT

AT&T is upgraded to Strong Buy, reflecting improved FCF guidance, pricing power, and earnings acceleration. T now guides FCF to $18B for 2026, with coverage and dividend growth prospects improving an

Celestica delivered 62% revenue growth and 83% adjusted EPS growth, supported by strong AI infrastructure demand and expanding operating leverage. The Communications and Cloud Solutions segment genera

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2026) - Lion Rock Resources Inc. (TSXV: ROAR) (OTCQB: LRRIF) (FSE: KGB) ("Lion Rock" or the "Company") has completed a property-wide surface e

Customers can help support Rodale Institute's Farmer Training and Veteran Farmer Training programs while enjoying special savings, education and Organic Month events LAKEWOOD, Colo., Aug. 27, 2026 /PR

Marks and Spencer Group PLC (LSE:MKS) and Primark, owned by Associated British Foods PLC (LSE:ABF), sit on opposite sides of a shifting UK retail divide created by recent heatwave trading, according t

Urban Outfitters is upgraded to a "Buy" as free cash flow and sales momentum accelerate, with shares poised to break out of consolidation. Nuuly, URBN's subscription business, is a key differentiator,